Clinical trial
A Multi-center, Open Label, Randomised Parallel- Group Study to Compare the Efficacy of Cholestyramine Plus Standard Treatment Versus Prednisolone Plus Standard Treatment Versus Standard Treatment Alone in Treatment of Overt Hyperthyroidism
NCT03303053 is registered in ClinicalTrials.gov with Clinical Research Centre, Malaysia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multi-center, Open Label, Randomised Parallel- Group Study to Compare the Efficacy of Cholestyramine Plus Standard Treatment Versus Prednisolone Plus Standard Treatment Versus Standard Treatment Alone in Treatment of Overt Hyperthyroidism
- Lead sponsor
- Clinical Research Centre, Malaysia
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- May 11, 2017
- Completion date
- March 1, 2018
- Enrollment
- 135 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.